Century Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Century Therapeutics, Inc. (IPSC) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-126.57-136.67-130.93-95.82-53.58
Depreciation & Amortization13.3013.048.443.751.40
Deferred Income Tax0.870.000.000.000.00
Stock Based Compensation12.6914.6210.674.660.88
Change in Working Capital-9.289.38123.95-2.804.86
Change in Accounts Payable-1.47-2.36-4.79-1.852.06
Change in Other Working Capital-1.2213.9810.751.212.80
Other Operating Activities0.20-1.201.631.210.35
Net Cash from Operating Activities-110.14-88.3514.05-89.00-41.27
Investing Activities
Capital Expenditures-0.15-13.74-30.60-44.97-9.83
Acquisitions-9.610.000.000.00-4.72
Purchases of Investments57.2474.8717.48-330.03-8.21
Sales/Maturities of Investments176.79283.9017.4876.670.00
Net Cash from Investing Activities47.4861.13-13.13-298.34-22.76
Financing Activities
Debt Repayment0.00-10.240.000.000.00
Common Stock Issued74.560.5227.16221.6238.10
Other Financing Activities0.000.000.0034.23-0.14
Net Cash from Financing Activities74.56-9.7327.16417.7747.69
Summary
Net Change in Cash11.91-36.9428.0830.43-16.34
Cash at Beginning of Period49.3086.2458.1627.730.00
Cash at End of Period61.2149.3086.2458.160.00
Free Cash Flow-110.29-102.08-16.55-133.97-51.09
Supplemental Disclosures
Interest Paid0.000.591.100.970.21
Income Taxes Paid0.502.520.000.010.00